Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.
Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single ...
This ground-breaking first procedure not only marks the launch of the THOR ... laser catheter integrates two critical PAD treatments into a single device, significantly simplifying the treatment ...
Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery ...
"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.